Immediate Implant Placement in the Esthetic Zone

NCT01533571 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2015-03-09

No results posted yet for this study

Summary

This study aims to examine dimensional alveolar ridge alterations and prevent buccal plate resorption and soft tissue recession following immediate implant placement in extraction sockets in the maxillary esthetic zone using different socket morphology-guided treatment modalities.

Expected results of the study are:

* To have found the optimal materials and GBR procedures modalities for buccal plate resorption degree reduction;
* Soft tissue recession and best esthetic result achievement. There will be possibilities to study socket morphology influence on final esthetic result achievement.

Conditions

  • Unspecified Atrophy of Edentulous Alveolar Ridge

Interventions

PROCEDURE

Immediate implant placement with simultaneous bone grafting

* Flapless surgery is used for surgical implant installation. * Implant is placed in the cingulum position of adjacent teeth incisal edge. * After placement of optimal implant the remaining gap between the implant and the surrounding bony walls should be at least 2 mm or should be need for GBR of buccal plate outside the socket. * Two types of bone graft materials will be applied for two groups of patients: Group I - natural bovine bone grafting material + resorbable natural soft tissue membrane; Group II - processed human allograft + resorbable natural soft tissue membrane . Crown can be fixed on abutment if there is initial stability under 35 Ncm insertion torque. If insertion torque will be less, crown should be bond to neighboring teeth using composite material.

Sponsors & Collaborators

  • Hacettepe University

    collaborator OTHER
  • Universidad de Granada

    collaborator OTHER
  • University of Michigan

    collaborator OTHER
  • Lithuanian University of Health Sciences

    lead OTHER

Principal Investigators

  • Gintaras Juodzbalys, Professor · Lithuanian University of Health Sciences (Lithuania)

  • Hom-Lay Wang, Professor · University of Michigan

  • Pablo Galindo-Moreno, Professor · University of Granada (Spain)

  • Tolga F Tozum, Professor · Hacettepe University (Turkey)

  • Povilas Daugela, Dr. · Lithuanian University of Health Sciences (Lithuania)

  • Algirdas Puisys, Dr. · Lithuanian University of Health Sciences (Lithuania)

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-01-31
Primary Completion
2016-04-30
Completion
2016-12-31

Countries

  • United States
  • Lithuania
  • Spain
  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01533571 on ClinicalTrials.gov